Novo Nordisk to Release new Diabetes DrugBy Mayuri, Gaea News Network
Friday, December 24, 2010
LOS ANGELES (GaeaTimes.com) — Danish pharmaceutical company Novo Nordisk said Thursday it planned to put a new insulin product on the market by 2013 after tests showed advantages to the widely sold diabetes drug Lantus.
Novo Nordisk on Thursday released results of studies it said showed that its product, Degludec, reduced the risk of dangerous drops in blood sugar levels during the night by 25 percent compared to Lantus, which is manufactured by the French company Sanofi-Aventis.
According to the World Health Organisation, more than 220 million people worldwide have diabetes, which occurs when the body cannot produce insulin to regulate blood sugar levels or cannot use natural insulin effectively due to overweight and absence of sufficient exercise.